Cargando…
The effect of pelvic pathology on uterine vein diameters
BACKGROUND: Transvaginal ultrasound (TVS) is a sensitive tool for detecting various conditions that contribute to pelvic pain. TVS can be also used to assess blood flow and measure the size of pelvic veins. Pelvic venous congestion (PVC) is characterised by enlargement of the pelvic veins and has be...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892655/ https://www.ncbi.nlm.nih.gov/pubmed/33599877 http://dx.doi.org/10.1186/s13089-021-00212-y |
_version_ | 1783652891087601664 |
---|---|
author | Amin, T. N. Wong, M. Foo, X. Pointer, S.-L. Goodhart, V. Jurkovic, D. |
author_facet | Amin, T. N. Wong, M. Foo, X. Pointer, S.-L. Goodhart, V. Jurkovic, D. |
author_sort | Amin, T. N. |
collection | PubMed |
description | BACKGROUND: Transvaginal ultrasound (TVS) is a sensitive tool for detecting various conditions that contribute to pelvic pain. TVS can be also used to assess blood flow and measure the size of pelvic veins. Pelvic venous congestion (PVC) is characterised by enlargement of the pelvic veins and has been recognised as a cause of chronic pelvic pain. The reference ranges for uterine venous diameter in women with normal pelvic organs have been established, but there is no information regarding the potential effect of pelvic pathology on the uterine venous diameters. The aim of this study was to examine the size of uterine venous plexus in women with evidence of pelvic abnormalities on TVS and to determine whether the reference ranges need to be adjusted in the presence of pelvic pathology. A prospective, observational study was conducted in our gynaecological outpatient clinic. Morphological characteristics of all pelvic abnormalities detected on TVS and their sizes were recorded. The uterine veins were identified and their diameters were measured in all cases. The primary outcome measure was the uterine venous diameter. Regression analyses were performed to determine factors affecting the uterine venous size in women with pelvic pathology. RESULTS: A total of 1500 women were included into the study, 1014 (67%) of whom were diagnosed with pelvic abnormalities. Women with pelvic pathology had significantly larger uterine venous diameters than women with normal pelvic organs (p < 0.01). Multivariable analysis showed that pre-menopausal status, high parity, presence of fibroids (p < 0.001) and Black ethnicity were all associated with significantly larger uterine vein diameters. Based on these findings modified reference ranges for uterine venous diameters have been designed which could be used for the diagnosis of PVC in women with uterine fibroids. CONCLUSIONS: Our findings show that of all pelvic pathology detected on TVS, only fibroids are significantly associated with uterine venous enlargement. Factors known to be associated with enlarged veins in women with normal pelvic organs, namely parity and menopausal status, also apply in patients with pelvic pathology. Future studies of uterine venous circulation should take into account the presence and size of uterine fibroids when assessing women for the signs of PVC. |
format | Online Article Text |
id | pubmed-7892655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-78926552021-03-03 The effect of pelvic pathology on uterine vein diameters Amin, T. N. Wong, M. Foo, X. Pointer, S.-L. Goodhart, V. Jurkovic, D. Ultrasound J Original Article BACKGROUND: Transvaginal ultrasound (TVS) is a sensitive tool for detecting various conditions that contribute to pelvic pain. TVS can be also used to assess blood flow and measure the size of pelvic veins. Pelvic venous congestion (PVC) is characterised by enlargement of the pelvic veins and has been recognised as a cause of chronic pelvic pain. The reference ranges for uterine venous diameter in women with normal pelvic organs have been established, but there is no information regarding the potential effect of pelvic pathology on the uterine venous diameters. The aim of this study was to examine the size of uterine venous plexus in women with evidence of pelvic abnormalities on TVS and to determine whether the reference ranges need to be adjusted in the presence of pelvic pathology. A prospective, observational study was conducted in our gynaecological outpatient clinic. Morphological characteristics of all pelvic abnormalities detected on TVS and their sizes were recorded. The uterine veins were identified and their diameters were measured in all cases. The primary outcome measure was the uterine venous diameter. Regression analyses were performed to determine factors affecting the uterine venous size in women with pelvic pathology. RESULTS: A total of 1500 women were included into the study, 1014 (67%) of whom were diagnosed with pelvic abnormalities. Women with pelvic pathology had significantly larger uterine venous diameters than women with normal pelvic organs (p < 0.01). Multivariable analysis showed that pre-menopausal status, high parity, presence of fibroids (p < 0.001) and Black ethnicity were all associated with significantly larger uterine vein diameters. Based on these findings modified reference ranges for uterine venous diameters have been designed which could be used for the diagnosis of PVC in women with uterine fibroids. CONCLUSIONS: Our findings show that of all pelvic pathology detected on TVS, only fibroids are significantly associated with uterine venous enlargement. Factors known to be associated with enlarged veins in women with normal pelvic organs, namely parity and menopausal status, also apply in patients with pelvic pathology. Future studies of uterine venous circulation should take into account the presence and size of uterine fibroids when assessing women for the signs of PVC. Springer International Publishing 2021-02-18 /pmc/articles/PMC7892655/ /pubmed/33599877 http://dx.doi.org/10.1186/s13089-021-00212-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Amin, T. N. Wong, M. Foo, X. Pointer, S.-L. Goodhart, V. Jurkovic, D. The effect of pelvic pathology on uterine vein diameters |
title | The effect of pelvic pathology on uterine vein diameters |
title_full | The effect of pelvic pathology on uterine vein diameters |
title_fullStr | The effect of pelvic pathology on uterine vein diameters |
title_full_unstemmed | The effect of pelvic pathology on uterine vein diameters |
title_short | The effect of pelvic pathology on uterine vein diameters |
title_sort | effect of pelvic pathology on uterine vein diameters |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892655/ https://www.ncbi.nlm.nih.gov/pubmed/33599877 http://dx.doi.org/10.1186/s13089-021-00212-y |
work_keys_str_mv | AT amintn theeffectofpelvicpathologyonuterineveindiameters AT wongm theeffectofpelvicpathologyonuterineveindiameters AT foox theeffectofpelvicpathologyonuterineveindiameters AT pointersl theeffectofpelvicpathologyonuterineveindiameters AT goodhartv theeffectofpelvicpathologyonuterineveindiameters AT jurkovicd theeffectofpelvicpathologyonuterineveindiameters AT amintn effectofpelvicpathologyonuterineveindiameters AT wongm effectofpelvicpathologyonuterineveindiameters AT foox effectofpelvicpathologyonuterineveindiameters AT pointersl effectofpelvicpathologyonuterineveindiameters AT goodhartv effectofpelvicpathologyonuterineveindiameters AT jurkovicd effectofpelvicpathologyonuterineveindiameters |